Diagnosis of polycystic ovary syndrome
- PMID: 17304034
- DOI: 10.1097/GRF.0b013e31802f351b
Diagnosis of polycystic ovary syndrome
Abstract
Polycystic ovary syndrome (PCOS) is a diagnosis of exclusion, with other androgen excess and ovulatory dysfunction disorders to be ruled out. There are 3 principal features of the syndrome, including hyperandrogenism, ovulatory dysfunction, and polycystic ovarian morphology. These features have been included in slightly different permutations in the 3 criteria currently available to diagnose PCOS, including that of the National Institutes of Health (NIH) 1990, Rotterdam 2003, and the Androgen Excess Society 2006. Overall, at least 1 in 15 women of reproductive age will be affected by PCOS, making this disorder the most common endocrine abnormality in this age group, with a health burden of over 4 billion dollars in the United States alone.
Similar articles
-
Diagnosis, epidemiology, and genetics of the polycystic ovary syndrome.Best Pract Res Clin Endocrinol Metab. 2006 Jun;20(2):193-205. doi: 10.1016/j.beem.2006.02.005. Best Pract Res Clin Endocrinol Metab. 2006. PMID: 16772151 Review.
-
The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria.Hum Reprod. 2010 Feb;25(2):544-51. doi: 10.1093/humrep/dep399. Epub 2009 Nov 12. Hum Reprod. 2010. PMID: 19910321
-
Diagnosis, phenotype, and prevalence of polycystic ovary syndrome.Fertil Steril. 2006 Jul;86 Suppl 1:S7-8. doi: 10.1016/j.fertnstert.2006.03.012. Fertil Steril. 2006. PMID: 16798288
-
PCOS according to the Rotterdam consensus criteria: Change in prevalence among WHO-II anovulation and association with metabolic factors.BJOG. 2006 Oct;113(10):1210-7. doi: 10.1111/j.1471-0528.2006.01008.x. BJOG. 2006. PMID: 16972863
-
[Current diagnosis of polycystic ovary syndrome: expanding the phenotype but generating new questions].Rev Med Chil. 2009 Aug;137(8):1071-80. Epub 2009 Nov 4. Rev Med Chil. 2009. PMID: 19915773 Review. Spanish.
Cited by
-
Effect of Treatment with Metformin on Omentin-1, Ghrelin and other Biochemical, Clinical Features in PCOS Patients.Oman Med J. 2010 Oct;25(4):289-93. doi: 10.5001/omj.2010.84. Oman Med J. 2010. PMID: 22043360 Free PMC article.
-
A subpathway-based method of drug reposition for polycystic ovary syndrome.Reprod Sci. 2015 Apr;22(4):423-30. doi: 10.1177/1933719114542025. Epub 2014 Jul 11. Reprod Sci. 2015. PMID: 25015903 Free PMC article.
-
The Improvement Effect of D-Chiro-Inositol and Ecklonia cava K. in the Rat Model of Polycystic Ovarian Syndrome.Front Pharmacol. 2022 Jul 19;13:905191. doi: 10.3389/fphar.2022.905191. eCollection 2022. Front Pharmacol. 2022. PMID: 35928256 Free PMC article.
-
Ultrasound-guided transvaginal ovarian needle drilling for clomiphene-resistant polycystic ovarian syndrome in subfertile women.Cochrane Database Syst Rev. 2021 Nov 4;11(11):CD008583. doi: 10.1002/14651858.CD008583.pub3. Cochrane Database Syst Rev. 2021. PMID: 34735019 Free PMC article.
-
Improvement in quality-of-life questionnaire measures in obese adolescent females with polycystic ovary syndrome treated with lifestyle changes and oral contraceptives, with or without metformin.Fertil Steril. 2010 Feb;93(3):1016-9. doi: 10.1016/j.fertnstert.2009.08.006. Epub 2009 Sep 24. Fertil Steril. 2010. PMID: 19781696 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical